Cargando…

The impact of ocrelizumab on health-related quality of life in individuals with multiple sclerosis

BACKGROUND: Ocrelizumab is approved for the treatment of both relapsing and progressive multiple sclerosis (MS). OBJECTIVE: To examine the impact of ocrelizumab on health-related quality of life (HRQOL) in individuals with MS. METHODS: Ninety-eight individuals with relapsing and 32 with progressive...

Descripción completa

Detalles Bibliográficos
Autores principales: Glanz, Bonnie I, Zurawski, Jonathan, Casady, Emily C, Shamah, Rebecca, Weiner, Mira, Chitnis, Tanuja, Weiner, Howard L, Healy, Brian C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8138295/
https://www.ncbi.nlm.nih.gov/pubmed/34046184
http://dx.doi.org/10.1177/20552173211007523

Ejemplares similares